# XR-Assisted PET/CT Navigation for Cervical Lymph Node Dissection in Lung Cancer

> **NCT07593872** · NA · NOT_YET_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer
- Lymph Node Metastasis
- Supraclavicular Lymph Node Metastasis

## Interventions

- **DEVICE:** OpVerse XR Surgical Planning Platform with HoloLens HMD
- **PROCEDURE:** Cervical / Supraclavicular Lymph Node Dissection

## Key facts

- **NCT ID:** NCT07593872
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07593872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07593872, "XR-Assisted PET/CT Navigation for Cervical Lymph Node Dissection in Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07593872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*